Testing Piemonte combination pill in adults with type 2 diabetes
Tests the Piemonte combination against placebo in adults with type 2 diabetes.
Plain-language title generated from the registry record
Registry title: Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus
Key facts
- Where
- Hortolândia, BrazilSee the site
- Phase
- Phase 3
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 85 years old?
Source: NCT05028140, who can take part
Where in Brazil
- EMSHortolândia, BrazilTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- EMS
- Trial code
- NCT05028140
- Record updated
- 8 December 2025
- Original description
The purpose of this study is to evaluate the efficacy and safety of Piemonte association in the treatment of type 2 diabetes mellitusRead full original descriptionShow less
National, Multicenter, Randomized, Double-blind, Triple-dummy, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus
The purpose of this study is to evaluate the efficacy and safety of Piemonte association in the treatment of type 2 diabetes mellitus
Inclusion: Ability to confirm voluntary participation and agree to all trial purposes by signing and dating the consent form; Diagnosis of type II diabetes mellitus, and who did not reach the therapeutic goal of HbA1c with previous dietary, physical exercise, and previous therapies at stable doses within 3 months.
Exclusion: Participation in a clinical trial in the year prior to this study; History of alcohol abuse or illicit drug use; Known hypersensitivity to any of the formula compounds; Type 1 diabetes; Any clinical and laboratory findings that, in the judgment of the investigator, may interfere with the safety of participants; Pregnancy or risk of pregnacy and lactating participants.